University of Arizona

BioCentury’s roundup of translational innovations also includes a blood-based T cell assay for T1D, a degrader using a new E3 ligase, and papers from newcos

Plus: Foundery raising $160M for first fund, Apellis shares bounce back and updates from Cellares, Agenus, Pfizer, Astellas and more

Companies dial in subtype selectivity, explore new modalities, and move to more homogeneous trial populations

Syncona’s first allogeneic cell therapy investment goes to Clade, led by Sana and CRISPR Therapeutics co-founder Cowan

BioCentury’s roundup of translational news

DISEASE CATEGORY: Infectious disease
INDICATION: Fungal infection Small molecule inhibitors of a Cryptococcus spp. intein-containing intron splicing factor PRPF8 could treat infections by

A look at the barriers to mass asymptomatic testing, and the path to removing them

ProNeurogen is tackling vascular cognitive impairment with angiotensin peptides